Aim to utilize BioAI's PredictX platform to develop AI-based models using Arbele's clinical trial data, specifically focusing on screening biomarkers for CRC.
Will support drug development from early clinical studies through regulatory approval with efficient, flexible and streamlined companion diagnostic development.